Posts by camerontucker
Best CD34+ Cell Suppliers for 2026: Comparing Bone Marrow, Cord Blood, and Mobilized Sources
Introduction CD34+ cells are the foundation of regenerative medicine and immunotherapy research. These hematopoietic stem and progenitor cells (HSPCs) are used in applications ranging from CAR-T and NK cell manufacturing to gene editing and transplant modeling. In 2026, researchers can source CD34+ cells from several isolation routes — each with its own yield, viability, and…
For More InformationBest Mobilized Leukopak Suppliers for 2026: G-CSF vs. Plerixafor Compared
Introduction Mobilized leukopaks are essential starting material for advanced cell therapies, immune research, and manufacturing optimization. By mobilizing hematopoietic stem and progenitor cells (HSPCs) from the bone marrow into the bloodstream using agents like G-CSF or plerixafor, researchers can isolate higher yields of CD34+ and target immune cells for CAR T, NK, and other immunotherapy…
For More InformationMeet CGT Global’s Scientific Team: Sophia Johnson Associate Director of Logistic Operations
For cell procurement and delivery operations to run smoothly, countless moving parts must align. From understanding the needs of a research project to scheduling donors, fulfilling orders, and ensuring precise delivery, every step must fit together seamlessly. So, who keeps everything ticking like a perfectly timed clock? Meet Sophia Johnson, Associate Director of Logistic Operations at CGT Global. Sophia has been with…
For More InformationScaling Humanized Immune System Mouse Models: Optimize Your CD34+ Engraftment with High Quality Cells
Table of Contents CD34+ Humanized Immune System Mice MNC Cell Quality Assessment: Flow Cytometry Data from CGT Global Cell Viability Cell Purity Cell Count Sources of CD34+ Cells: Comparison Table for Bone Marrow and Cord Blood Bulk Isolated CD34+ for Humanized Mice About CGT Global and Additional Resources Frequently Asked Questions List of Abbreviations The…
For More InformationTop PBMC Suppliers for 2026: Fresh, Cryopreserved, and GMP-Grade Options Compared
Introduction Peripheral Blood Mononuclear Cells (PBMCs) are foundational to immunology, oncology, and cell therapy research. Whether they are used for functional assays, vaccine development, or discovery-stage therapeutic studies, PBMC quality directly impacts data accuracy and reproducibility. In 2026, researchers expect more than just availability. They look for documented donor screening, consistent viability, and responsive support.…
For More InformationBest Leukopak Suppliers for Cell Therapy in 2026: Pricing, Quality, and Turnaround Compared
Introduction When it comes to sourcing leukopaks for cell therapy or research, product quality is only half the story. Procurement delays, unanswered inquiries, and limited visibility can stall entire workflows. In 2026, speed and communication matter just as much as purity and yield. To help researchers, process developers, and procurement teams choose confidently, we reviewed…
For More InformationThe Donors Powering Breakthroughs in Maternal and Infant Health
Become a Donor 📞 Call or Text (916) 350-0714 Every great discovery begins with a volunteer. At CGT Global, maternal blood donors are at the heart of pregnancy and infant health research. Their contributions help scientists understand how life begins, how the body adapts during pregnancy, and how to prevent complications that still threaten mothers and…
For More InformationScaling Cell & Gene Therapy Development: How CGT Global Supports Research, Clinical Trials, and Commercialization
By Joanna Wirkus, PhD From RUO to cGMP, CGT Global delivers quality, consistency, and regulatory readiness to help researchers advance therapies from discovery to patients. Executive Summary CGT Global accelerates cell and gene therapy development from discovery to commercialization. By providing rapid and reliable access to high-quality RUO and cGMP-certified materials and operating FDA- and CLIA-certified…
For More InformationMeet CGT Global’s Scientific Team: Vanessa Murillo – Supervisor, Client Scientific Associate Team
October 08, 2025 Written by: Joanna Wirkus, PhD At CGT Global, advancing scientific discoveries worldwide by delivering high-quality biospecimens starts with providing exceptional service to our clients. Today, we’re highlighting how this happens by speaking with Vanessa Murillo, a core member and leader of CGT Global’s Client Scientific Associate team. Vanessa is a Client Scientific…
For More Information5 Green Flags the FDA Looks for in CGT CMC and How to Get Them
Roughly 50 to 75 percent of FDA rejections in cell and gene therapy are not about safety or efficacy. They are due to CMC and manufacturing deficiencies. In short, most programs do not fail because the science does not work. They fail because the manufacturing story is not strong enough. (Sources: Jefferies analysis of FDA…
For More Information